WO1996040660A1 - Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands - Google Patents
Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands Download PDFInfo
- Publication number
- WO1996040660A1 WO1996040660A1 PCT/US1996/005843 US9605843W WO9640660A1 WO 1996040660 A1 WO1996040660 A1 WO 1996040660A1 US 9605843 W US9605843 W US 9605843W WO 9640660 A1 WO9640660 A1 WO 9640660A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound according
- cyclohexane
- phenylpiperazin
- lower alkyl
- phenyl
- Prior art date
Links
- 0 COc1cccc([*+])c1 Chemical compound COc1cccc([*+])c1 0.000 description 2
- OEHZSKGXHZXRGI-UHFFFAOYSA-N CCOc1cccc(C(CC2)(CCC2O)N(CC2)CCN2c2ccccc2)c1 Chemical compound CCOc1cccc(C(CC2)(CCC2O)N(CC2)CCN2c2ccccc2)c1 OEHZSKGXHZXRGI-UHFFFAOYSA-N 0.000 description 1
- YJDQJXGEGSVZSO-XVTQMYCESA-N C[C@H](CC1)CC[C@@]1(c1cc(OCc2ccccc2)ccc1)N(CC1)CCN1c1ccccc1 Chemical compound C[C@H](CC1)CC[C@@]1(c1cc(OCc2ccccc2)ccc1)N(CC1)CCN1c1ccccc1 YJDQJXGEGSVZSO-XVTQMYCESA-N 0.000 description 1
- PZDUQDUNYLFCCD-UHFFFAOYSA-N Oc1cc(I)cc(O)c1 Chemical compound Oc1cc(I)cc(O)c1 PZDUQDUNYLFCCD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9500490A JPH10507203A (en) | 1995-06-07 | 1996-04-26 | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1-specific ligands |
EP96913198A EP0833823A1 (en) | 1995-06-07 | 1996-04-26 | Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
AU55787/96A AU5578796A (en) | 1995-06-07 | 1996-04-26 | Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
BR9609334A BR9609334A (en) | 1995-06-07 | 1996-04-26 | Certain benzylamine derivatives replaced a new class of specific Y1 neuropeptide linkers |
MXPA/A/1997/009980A MXPA97009980A (en) | 1995-06-07 | 1997-12-08 | Certain substitute bencilamine derivatives: unanueva class of neuropeptide specific ligands |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47838395A | 1995-06-07 | 1995-06-07 | |
US48497495A | 1995-06-07 | 1995-06-07 | |
US08/484,974 | 1995-06-07 | ||
US08/478,383 | 1995-06-07 | ||
USPCT/US95/14472 | 1995-11-07 | ||
PCT/US1995/014472 WO1996014307A1 (en) | 1994-11-07 | 1995-11-07 | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996040660A1 true WO1996040660A1 (en) | 1996-12-19 |
Family
ID=27045885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/005843 WO1996040660A1 (en) | 1995-06-07 | 1996-04-26 | Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0833823A1 (en) |
JP (1) | JPH10507203A (en) |
AU (1) | AU5578796A (en) |
BR (1) | BR9609334A (en) |
CA (1) | CA2220958A1 (en) |
CO (1) | CO4700426A1 (en) |
IL (1) | IL117997A0 (en) |
MA (1) | MA23860A1 (en) |
PE (1) | PE34297A1 (en) |
TR (1) | TR199600382A2 (en) |
WO (1) | WO1996040660A1 (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003493A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
WO1998003494A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
WO1998003492A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
WO1998035944A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amides as npy5 receptor antagonists |
WO1998035957A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
WO2004098591A2 (en) | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
EP1507504A1 (en) * | 2002-02-01 | 2005-02-23 | Bristol-Myers Squibb Company | Cycloalkyl inhibitors of potassium channel function |
WO2005075436A2 (en) | 2004-02-05 | 2005-08-18 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
WO2008104580A1 (en) | 2007-03-01 | 2008-09-04 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
WO2011029920A1 (en) | 2009-09-11 | 2011-03-17 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
EP2338490A2 (en) | 2003-11-03 | 2011-06-29 | Probiodrug AG | Combinations Useful for the Treatment of Neuronal Disorders |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
WO2011110613A1 (en) | 2010-03-10 | 2011-09-15 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
US8153828B2 (en) | 1998-12-14 | 2012-04-10 | Life Technologies Corporation | Optical molecular sensors for cytochrome P450 activity |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
EP2865670A1 (en) | 2007-04-18 | 2015-04-29 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
EP3461819A1 (en) | 2017-09-29 | 2019-04-03 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2352631A1 (en) * | 1998-12-14 | 2000-06-22 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome p450 activity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4845221A (en) * | 1988-04-15 | 1989-07-04 | American Home Products Corporation | Serotonergic substituted piperazinyl tetralins |
EP0395312A2 (en) * | 1989-04-22 | 1990-10-31 | JOHN WYETH & BROTHER LIMITED | Piperazine derivatives |
-
1996
- 1996-04-22 IL IL11799796A patent/IL117997A0/en unknown
- 1996-04-26 CA CA002220958A patent/CA2220958A1/en not_active Abandoned
- 1996-04-26 AU AU55787/96A patent/AU5578796A/en not_active Abandoned
- 1996-04-26 EP EP96913198A patent/EP0833823A1/en not_active Withdrawn
- 1996-04-26 JP JP9500490A patent/JPH10507203A/en active Pending
- 1996-04-26 BR BR9609334A patent/BR9609334A/en not_active Application Discontinuation
- 1996-04-26 WO PCT/US1996/005843 patent/WO1996040660A1/en not_active Application Discontinuation
- 1996-05-08 CO CO96022963A patent/CO4700426A1/en unknown
- 1996-05-08 PE PE1996000325A patent/PE34297A1/en not_active Application Discontinuation
- 1996-05-08 MA MA24226A patent/MA23860A1/en unknown
- 1996-05-10 TR TR96/00382A patent/TR199600382A2/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4845221A (en) * | 1988-04-15 | 1989-07-04 | American Home Products Corporation | Serotonergic substituted piperazinyl tetralins |
EP0395312A2 (en) * | 1989-04-22 | 1990-10-31 | JOHN WYETH & BROTHER LIMITED | Piperazine derivatives |
Non-Patent Citations (2)
Title |
---|
AL-DEEB, O. A. ET AL.: "Synthesis of New (1-Phenylcyclohexyl) Piperazine Derivatives as Potential Analgegesics", BULL. PHAC. PHARM. (CAIRO UNIV.), vol. 31, no. 3, - 1993, pages 475 - 479, XP002008428 * |
GRUNDEMAR, L. AND HAKANSON, R., TIPS, vol. 15, - 15 April 1994 (1994-04-15), pages 153 - 159, XP002008429 * |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962455A (en) * | 1996-07-23 | 1999-10-05 | Neurogen Corporation | Certain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligands |
WO1998003494A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
WO1998003492A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
WO1998003493A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
US6316617B1 (en) | 1996-07-23 | 2001-11-13 | Neurogen Corporation | Certain amido-and amino-substituted benzylamine derivatives; a new class of Neuropeptide Y1 specific ligands |
US6133265A (en) * | 1996-07-23 | 2000-10-17 | Neurogen Corporation | Certain amido- and amino- substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands |
WO1998035957A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US5939462A (en) * | 1997-02-14 | 1999-08-17 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
US6410792B1 (en) | 1997-02-14 | 2002-06-25 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
WO1998035944A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amides as npy5 receptor antagonists |
US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
US8153828B2 (en) | 1998-12-14 | 2012-04-10 | Life Technologies Corporation | Optical molecular sensors for cytochrome P450 activity |
AU2003210817B2 (en) * | 2002-02-01 | 2009-07-16 | Bristol-Myers Squibb Company | Cycloalkyl inhibitors of potassium channel function |
EP1507504A1 (en) * | 2002-02-01 | 2005-02-23 | Bristol-Myers Squibb Company | Cycloalkyl inhibitors of potassium channel function |
EP1507504A4 (en) * | 2002-02-01 | 2006-07-05 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
EP2253328A1 (en) * | 2002-02-01 | 2010-11-24 | Bristol-Myers Squibb Company | Cycloalkyl inhibitors of potassium channel function |
AU2003210817B9 (en) * | 2002-02-01 | 2009-10-29 | Bristol-Myers Squibb Company | Cycloalkyl inhibitors of potassium channel function |
WO2004098591A2 (en) | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
EP2338490A2 (en) | 2003-11-03 | 2011-06-29 | Probiodrug AG | Combinations Useful for the Treatment of Neuronal Disorders |
WO2005075436A2 (en) | 2004-02-05 | 2005-08-18 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
WO2008104580A1 (en) | 2007-03-01 | 2008-09-04 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
EP2481408A2 (en) | 2007-03-01 | 2012-08-01 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
EP2865670A1 (en) | 2007-04-18 | 2015-04-29 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
WO2011029920A1 (en) | 2009-09-11 | 2011-03-17 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
WO2011110613A1 (en) | 2010-03-10 | 2011-09-15 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
EP3461819A1 (en) | 2017-09-29 | 2019-04-03 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Also Published As
Publication number | Publication date |
---|---|
TR199600382A2 (en) | 1996-12-21 |
MA23860A1 (en) | 1996-12-31 |
BR9609334A (en) | 1999-05-25 |
MX9709980A (en) | 1998-03-29 |
IL117997A0 (en) | 1996-10-31 |
PE34297A1 (en) | 1997-09-24 |
JPH10507203A (en) | 1998-07-14 |
EP0833823A1 (en) | 1998-04-08 |
CA2220958A1 (en) | 1996-12-19 |
CO4700426A1 (en) | 1998-12-29 |
AU5578796A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2203878C (en) | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands | |
WO1996040660A1 (en) | Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands | |
EP0915859B1 (en) | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands | |
US6316617B1 (en) | Certain amido-and amino-substituted benzylamine derivatives; a new class of Neuropeptide Y1 specific ligands | |
US5985873A (en) | Certain substituted benzylamine derivatives a new class of Neuropeptide-Y1 specific ligands | |
JP3072737B2 (en) | Process for producing substituted cyclohexylimines | |
US5900415A (en) | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands | |
US6407120B1 (en) | Neuropeptide Y antagonists | |
US5166156A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
EP0111226A1 (en) | Carboximide derivatives, process for their production and medicines containing same | |
CA2299013C (en) | Neuropeptide y antagonists | |
EP0790989B1 (en) | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands | |
US5166157A (en) | Naphthyl piperazines useful as 5-HT1A receptor ligands | |
CA2272927C (en) | Dimesylate salts of neuropeptide y ligands | |
US5162321A (en) | 1-naphthyl piperazines useful as 5-HT1A receptor ligands | |
US5162324A (en) | Naphyl piperazines useful as 5-HT1A receptor ligands | |
DE19648384A1 (en) | New fluorene, dibenzofuran and dibenzothiophene derivatives | |
MXPA97009980A (en) | Certain substitute bencilamine derivatives: unanueva class of neuropeptide specific ligands | |
JP2010501007A (en) | Thiourea compounds | |
MXPA99000870A (en) | Certain substituteed benzylamine derivatives: a new class of neuropeptide specific ligands | |
MXPA97003349A (en) | Specific ligands of the neuropeptide | |
CN1205005A (en) | Certain substituted benzylamine derivatives, new class of neuropeptide Y1 specific ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US US US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1997 817642 Date of ref document: 19970429 Kind code of ref document: A Format of ref document f/p: F Ref country code: US Ref document number: 1997 817641 Date of ref document: 19970429 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2220958 Country of ref document: CA Ref country code: CA Ref document number: 2220958 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996913198 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1997/009980 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 1996913198 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996913198 Country of ref document: EP |